Higher dose and shorter tuberculosis treatment proven safe for patients medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
To assess incidence and predictors of unfavorable outcomes and its association with change in viral load among adult HIV/AIDS patients on second-line treatment.
/PRNewswire/ vasopharm GmbH ("vasopharm"), a privately-held biopharmaceutical company focusing on novel therapeutics to treat cerebrovascular diseases,.
- Improved neurologic outcome in young adults (18-39 years) with Ronopterin infused early - Significantly less aggressive critical care with maintained renal function in young adults -